World's Best Scientists 2026 revealed!
VIEW LIST
Charles D. Blanke

D-Index & Metrics

Medicine

D-Index
79
Citations
39845
World Ranking
17351
National Ranking
8694

Charles D. Blanke publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Charles D. Blanke sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 456 publications — 50th percentile

50% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Charles D. Blanke D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Charles D. Blanke sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 79 D-Index — 14th percentile

14% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Charles D. Blanke is affiliated with Oregon Health & Science University in the United States and has produced a substantial body of work in the field of medicine, particularly focusing on oncology and cancer research. Their research contributions span multiple subfields including pulmonary and respiratory medicine, pathology and forensic medicine, and surgery.

The scientist's research covers topics related to colorectal cancer treatments and studies, genetic factors in colorectal cancer, cancer genomics and diagnostics, cancer immunotherapy and biomarkers, gastric cancer management and outcomes, economic and financial impacts of cancer, and peptidase inhibition and analysis.

Frequent coauthors in their publications include Megan Othus, Young Kwang Chae, Razelle Kurzrock, Sandip Pravin Patel, and Elad Sharon, each collaborating on numerous projects.

Charles D. Blanke has published extensively in high-impact venues such as:

  • Journal of Clinical Oncology
  • Clinical Cancer Research
  • Cancer Research
  • Cancer
  • JAMA Network Open

Notable recent publications include:

  • A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART SWOG 1609) in Patients with Nonpancreatic Neuroendocrine Tumors (2020), Clinical Cancer Research
  • Multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART) (2021), Journal for ImmunoTherapy of Cancer
  • Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor (2023), Journal of Clinical Oncology
  • Effect of Celecoxib vs Placebo Added to Standard Adjuvant Therapy on Disease-Free Survival Among Patients With Stage III Colon Cancer (2021), JAMA
  • Biomarker-driven therapies for previously treated squamous non-small-cell lung cancer (Lung-MAP SWOG S1400): a biomarker-driven master protocol (2020), The Lancet Oncology

Best Publications

  • Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors.

    George Daniel Demetri;Margaret von Mehren;Charles D. Blanke;Annick Diane Van Den Abbeele

  • Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer

    Leonard B. Saltz;John V. Cox;Charles Blanke;Lee S. Rosen

  • Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor

    Michael C. Heinrich;Christopher L. Corless;George D. Demetri;Charles D. Blanke

  • Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial.

    Ronald P. DeMatteo;Karla V. Ballman;Cristina R. Antonescu;Robert G. Maki

  • Phase III Randomized, Intergroup Trial Assessing Imatinib Mesylate At Two Dose Levels in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing the Kit Receptor Tyrosine Kinase: S0033

    Charles D. Blanke;Cathryn Rankin;George D. Demetri;Christopher W. Ryan

  • Long-Term Results From a Randomized Phase II Trial of Standard- Versus Higher-Dose Imatinib Mesylate for Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing KIT

    Charles D Blanke;George D Demetri;Margaret von Mehren;Michael C Heinrich

  • NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)--update of the NCCN clinical practice guidelines.

    George D. Demetri;Robert S. Benjamin;Charles D. Blanke;Jean Yves Blay

  • Molecular Correlates of Imatinib Resistance in Gastrointestinal Stromal Tumors

    Michael C. Heinrich;Christopher L. Corless;Charles D. Blanke;George D. Demetri

  • Updated Analysis of SWOG-Directed Intergroup Study 0116: A Phase III Trial of Adjuvant Radiochemotherapy Versus Observation After Curative Gastric Cancer Resection

    Stephen R. Smalley;Jacqueline K. Benedetti;Daniel G. Haller;Scott A. Hundahl

  • Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial

    Alan P. Venook;Donna Niedzwiecki;Heinz Josef Lenz;Federico Innocenti

  • Inhibition of KIT Tyrosine Kinase Activity: A Novel Molecular Approach to the Treatment of KIT-Positive Malignancies

    Michael C. Heinrich;Charles D. Blanke;Brian J. Druker;Christopher L. Corless

  • Phase III Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma: Southwest Oncology Group–Directed Intergroup Trial S0205

    Philip A. Philip;Jacqueline Benedetti;Christopher L. Corless;Ralph Wong

  • Correlation of kinase genotype and clinical outcome in the North American Intergroup Phase III Trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group.

    Michael C. Heinrich;Kouros Owzar;Christopher L. Corless;Donna Hollis

  • Disease-Free Survival Versus Overall Survival As a Primary End Point for Adjuvant Colon Cancer Studies: Individual Patient Data From 20,898 Patients on 18 Randomized Trials

    Daniel J. Sargent;Harry S. Wieand;Daniel G. Haller;Richard Gray

  • Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): early results of RTOG 0132/ACRIN 6665.

    Burton L. Eisenberg;Jonathan Harris;Charles D. Blanke;George D. Demetri

  • CALGB/SWOG 80405: Phase III trial of irinotecan/5-FU/leucovorin (FOLFIRI) or oxaliplatin/5-FU/leucovorin (mFOLFOX6) with bevacizumab (BV) or cetuximab (CET) for patients (pts) with KRAS wild-type (wt) untreated metastatic adenocarcinoma of the colon or rectum (MCRC).

    Alan P. Venook;Donna Niedzwiecki;Heinz-Josef Lenz;Federico Innocenti

  • Imatinib Plasma Levels Are Correlated With Clinical Benefit in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumors

    George D. Demetri;Yanfeng Wang;Elisabeth Wehrle;Amy Racine

  • Phase II Trial of Erlotinib in Gastroesophageal Junction and Gastric Adenocarcinomas: SWOG 0127

    Tomislav Dragovich;Sheryl McCoy;Cecilia M. Fenoglio-Preiser;Jiang Wang

  • SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma

    Edgar Ben-Josef;Katherine A. Guthrie;Anthony B. El-Khoueiry;Christopher L. Corless

  • Impact of primary (1{o}) tumor location on overall survival (OS) and progression-free survival (PFS) in patients (pts) with metastatic colorectal cancer (mCRC): Analysis of CALGB/SWOG 80405 (Alliance).

    Alan P. Venook;Donna Niedzwiecki;Federico Innocenti;Briant Fruth

Frequent Co-Authors

Alan P. Venook
Alan P. Venook University of California, San Francisco
Heinz-Josef Lenz
Heinz-Josef Lenz University of Southern California
Donna Niedzwiecki
Donna Niedzwiecki Duke University
Richard M. Goldberg
Richard M. Goldberg West Virginia University
Federico Innocenti
Federico Innocenti University of North Carolina at Chapel Hill
Howard S. Hochster
Howard S. Hochster Yale University
Monica M. Bertagnolli
Monica M. Bertagnolli Brigham and Women's Hospital
Robert J. Mayer
Robert J. Mayer Dana-Farber Cancer Institute
George D. Demetri
George D. Demetri Dana-Farber Cancer Institute
Jeffrey A. Meyerhardt
Jeffrey A. Meyerhardt Harvard University

External Links

Personal website of Charles D. Blanke

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re exploring a medical career in the USA, it’s worth considering alternative online programs in healthcare. These pathways offer flexible and accessible entry points for a variety of professions, whether you’re interested in clinical care, administration, or health education.

Nursing remains a popular and rewarding field. For those looking to avoid lengthy prerequisite tests, some colleges now offer nursing schools that don't require teas, making entry more straightforward.

If leadership or management appeals to you, an accelerated healthcare administration degree can help you quickly enter the business side of healthcare.

Registered nurses can advance their practice and move toward specialized roles with asn to fnp programs, bridging the gap between an associate degree and a nurse practitioner license.

Those with a passion for nutrition science can launch or elevate their careers through an online degree in nutrition. This area supports roles in wellness, dietetics, and public health.

Best Scientists Citing Charles D. Blanke

Jean-Yves Blay

Jean-Yves Blay

Claude Bernard University Lyon 1

Publications: 74

Ronald P. DeMatteo

Ronald P. DeMatteo

University of Pennsylvania

Publications: 58

Michael Heinrich

Michael Heinrich

Oregon Health & Science University

Publications: 54

Margaret von Mehren

Margaret von Mehren

Fox Chase Cancer Center

Publications: 48

Volker Heinemann

Volker Heinemann

Ludwig-Maximilians-Universität München

Publications: 47

Heikki Joensuu

Heikki Joensuu

University of Helsinki

Publications: 46

Heinz-Josef Lenz

Heinz-Josef Lenz

University of Southern California

Publications: 44

George D. Demetri

George D. Demetri

Dana-Farber Cancer Institute

Publications: 43

Masatoshi Kudo

Masatoshi Kudo

Kindai University

Publications: 41

Piotr Rutkowski

Piotr Rutkowski

Maria Sklodowska-Curie National Research Institute of Oncology

Publications: 41

Axel Grothey

Axel Grothey

University of Tennessee at Knoxville

Publications: 41

Axel Le Cesne

Axel Le Cesne

Institut Gustave Roussy

Publications: 40

Chandrajit P. Raut

Chandrajit P. Raut

Brigham and Women's Hospital

Publications: 38

Christopher L. Corless

Christopher L. Corless

Oregon Health & Science University

Publications: 38

Paolo G. Casali

Paolo G. Casali

University of Milan

Publications: 37

Yoon-Koo Kang

Yoon-Koo Kang

Asan Medical Center

Publications: 37

Trending Scientists

Yeshayahu Talmon

Yeshayahu Talmon

Technion – Israel Institute of Technology

Baohua Li

Baohua Li

Tsinghua University

Sulabha K. Kulkarni

Sulabha K. Kulkarni

Indian Institute of Science

Kazuro Kikuchi

Kazuro Kikuchi

National Institution for Academic Degrees and Quality Enhancement of Higher Education

David S. Bennett

David S. Bennett

Drexel University

Paul J. Massman

Paul J. Massman

University of Houston

José A. Bauermeister

José A. Bauermeister

University of Pennsylvania

Guoying Bing

Guoying Bing

University of Kentucky

Marko Wilke

Marko Wilke

University of Tübingen

Fernando S. Rodrigo

Fernando S. Rodrigo

University of Almería

Andrew L. Goodman

Andrew L. Goodman

Yale University

Masahiko Aoki

Masahiko Aoki

Stanford University

Fuchen Wang

Fuchen Wang

East China University of Science and Technology

James A. Cowan

James A. Cowan

The Ohio State University

Christiaan Leeuwenburgh

Christiaan Leeuwenburgh

University of Florida

Thomas Brüning

Thomas Brüning

Ruhr University Bochum

Related Medicine Rankings & Guides

August 2026 Best Online Certificate Program in Medical Office Administration: Guide to Online Degrees

August 2026 Best Online Certificate Program in Medical Office Administration: Guide to Online Degrees
2026 Best Online CAHME-Accredited MHA Programs

2026 Best Online CAHME-Accredited MHA Programs
2026 Best Online Associate in Physical Therapy Assistant Programs

2026 Best Online Associate in Physical Therapy Assistant Programs
2026 Best Online MSN in Health/Nursing Informatics Programs

2026 Best Online MSN in Health/Nursing Informatics Programs
2026 Fastest Online Medical Assistant Associate Degree Programs

2026 Fastest Online Medical Assistant Associate Degree Programs
2026 Easiest Radiology Programs to Get Into

2026 Easiest Radiology Programs to Get Into
August 2026 Best Online Certificate Programs in Medical Billing & Coding Programs

August 2026 Best Online Certificate Programs in Medical Billing & Coding Programs
2026 Best Second-Degree BSN Programs

2026 Best Second-Degree BSN Programs
2026 Best Online MSN/MBA Dual Degree Programs

2026 Best Online MSN/MBA Dual Degree Programs
2026 Best Pathways to Pursue MSN without a BSN Degree

2026 Best Pathways to Pursue MSN without a BSN Degree
2026 Fastest Online BSN to MSN Bridge Programs

2026 Fastest Online BSN to MSN Bridge Programs
2026 Best Shortest Online PMHNP Certificate Programs

2026 Best Shortest Online PMHNP Certificate Programs
2026 Best Pharmacy Schools & Pharmacist Programs Requirements in Oklahoma: Online & Campus

2026 Best Pharmacy Schools & Pharmacist Programs Requirements in Oklahoma: Online & Campus
2026 Best Online Nursing Programs in Florida – Accredited RN to BSN Programs

2026 Best Online Nursing Programs in Florida – Accredited RN to BSN Programs
2026 Is Grand Canyon University School of Nursing Worth It?

2026 Is Grand Canyon University School of Nursing Worth It?
August 2026 Fast Track LPN Programs Online - 6, 9, 10, 11, 12 Month Programs

August 2026 Fast Track LPN Programs Online - 6, 9, 10, 11, 12 Month Programs
2026 Fastest Online RN to MSN (No ADN Required) Bridge Programs

2026 Fastest Online RN to MSN (No ADN Required) Bridge Programs
2026 Best Nurse Practitioner Programs in California – Accredited Schools Online & Campus

2026 Best Nurse Practitioner Programs in California – Accredited Schools Online & Campus
2026 Best Nurse Practitioner Programs in New Jersey – Accredited Schools Online & Campus

2026 Best Nurse Practitioner Programs in New Jersey – Accredited Schools Online & Campus
2026 Most Affordable Online BSN to MSN Bridge Programs

2026 Most Affordable Online BSN to MSN Bridge Programs
August 2026 Best Online Doctorate in Pharmacy (PharmD.) Programs

August 2026 Best Online Doctorate in Pharmacy (PharmD.) Programs

Recently Published Articles

2026 Online Speech Pathology Degree Programs Costs: Tuition & Fees

2026 Online Speech Pathology Degree Programs Costs: Tuition & Fees
2026 Cheapest Online PsyD Programs

2026 Cheapest Online PsyD Programs
2026 Highest Level of Ultrasound Technology Degree You Can Achieve: Academic Progression Explained

2026 Highest Level of Ultrasound Technology Degree You Can Achieve: Academic Progression Explained
2026 Library Science Degree Programs With Rolling Admissions

2026 Library Science Degree Programs With Rolling Admissions
2026 Cheapest and Shortest Online Nutrition Degree Programs That Pay Well: Cost, Duration, and Salary Outlook

2026 Cheapest and Shortest Online Nutrition Degree Programs That Pay Well: Cost, Duration, and Salary Outlook
2026 Cheapest and Shortest Online Healthcare Administration Degree Programs That Pay Well: Cost, Duration, and Salary Outlook

2026 Cheapest and Shortest Online Healthcare Administration Degree Programs That Pay Well: Cost, Duration, and Salary Outlook
2026 Does a Health Informatics Degree Require Internships or Clinical Hours?

2026 Does a Health Informatics Degree Require Internships or Clinical Hours?
2026 Best Online Social Psychology Degree Programs

2026 Best Online Social Psychology Degree Programs
2026 Sustainability Degree Programs With No GRE or GMAT Requirements

2026 Sustainability Degree Programs With No GRE or GMAT Requirements
2026 Best Psychology Schools in Utah – Accredited Colleges & Programs

2026 Best Psychology Schools in Utah – Accredited Colleges & Programs
2026 Self-Paced Online Information Security Degree Master's Programs

2026 Self-Paced Online Information Security Degree Master's Programs
2026 Cheapest Accredited Online Professional Writing Degree Programs: Tuition, Fees, and Financial Aid

2026 Cheapest Accredited Online Professional Writing Degree Programs: Tuition, Fees, and Financial Aid
2026 Creative Writing Career Outcomes by Degree Level Report: Pay, Employment, and Advancement Patterns

2026 Creative Writing Career Outcomes by Degree Level Report: Pay, Employment, and Advancement Patterns
2026 Online History Bachelor's Degree Programs With Accelerated Courses

2026 Online History Bachelor's Degree Programs With Accelerated Courses
2026 Hardest and Easiest Courses in a Positive Psychology Degree Program

2026 Hardest and Easiest Courses in a Positive Psychology Degree Program
2026 Best Accredited Online Medical Billing and Coding Schools With Financial Aid

2026 Best Accredited Online Medical Billing and Coding Schools With Financial Aid
2026 What Can You Do with a Criminology Degree? Costs & Job Opportunities

2026 What Can You Do with a Criminology Degree? Costs & Job Opportunities
2026 Online Biology and Biological Sciences Bachelor's Degree Programs With No Prerequisites

2026 Online Biology and Biological Sciences Bachelor's Degree Programs With No Prerequisites
2026 Animation Career Hotspots: Cities With the Best Pay, Job Openings, and Growth

2026 Animation Career Hotspots: Cities With the Best Pay, Job Openings, and Growth
2026 Cheapest and Shortest Online Management Information Systems Degree Programs That Pay Well: Cost, Duration, and Salary Outlook

2026 Cheapest and Shortest Online Management Information Systems Degree Programs That Pay Well: Cost, Duration, and Salary Outlook
August 2026 Fast Track LPN Programs Online - 6, 9, 10, 11, 12 Month Programs

August 2026 Fast Track LPN Programs Online - 6, 9, 10, 11, 12 Month Programs